Grants for Public and State controlled institutions of higher education - Food and Nutrition

Not available

This grant provides funding to organizations that promote vaccine confidence and health equity through partnerships and educational outreach, particularly targeting underserved populations across the United States.

The main objective of this NOFO is to foster development and testing of technologies adaptable to aging-related changes in older adults (aged 65 years or older) with T1D to improve diabetes management and quality of life. Older adults may have increased vulnerability to hypoglycemia, cognitive impairment and/or multiple co-morbidities which may affect the risks and benefits of these technologies in this population. Projects will be funded to a) develop and test new technologies and b) to adapt and test existing technologies. It is expected that aging-adaptive diabetes technologies that address barriers for use among older adults with T1D will improve usability, adoption and adherence decreasing the risk of hypoglycemia (and hypoglycemia unawareness) while enhancing glycemic control, facilitating better diabetes management, and improving quality of life for these individuals and their caregivers.

This funding opportunity supports independent research projects in health-related fields for a wide range of eligible applicants, including universities, nonprofits, and small businesses, without allowing clinical trials.

The Georgia Council for the Arts (GCA) is offering the 2024 Vibrant Communities Grants, a program designed to support single art projects across various counties in Georgia. This initiative aligns with the GCA's mission to increase the reach of arts grants statewide, as mandated by the Georgia Legislature. The program aims to fund diverse arts programs in as many counties as possible, thereby fostering vibrant cultural landscapes and promoting artistic engagement within communities. The grants are intended to enhance local arts scenes and provide opportunities for artistic expression and appreciation. The target beneficiaries of the Vibrant Communities Grants are non-profit organizations with 501(c)3 status, local government entities, public libraries, and schools, colleges, or universities located within specific eligible Georgia counties. The impact goals are to support and expand arts programs, ensuring broad access to cultural activities. This includes enabling various artistic endeavors such as performances, art exhibits, educational workshops, and artist residencies. By funding these projects, GCA seeks to enrich communities, provide creative outlets, and promote the arts as a vital component of local development. The program prioritizes a wide array of arts projects, including theatre productions, concerts, class field trips, art exhibits, murals, art festivals, and art classes. Notably, due to the ongoing impact of COVID, online programs are also eligible for funding. The focus is on projects that can be completed between October 15, 2024, and June 1, 2025, and must take place within the applicant's county. A key requirement is a 50% cash match for the grant request amount, emphasizing community investment and shared responsibility. Projects promoting specific religious doctrines or political parties are not eligible. Expected outcomes include a broader distribution of arts funding across Georgia, leading to an increase in local arts programming and engagement. Measurable results would be the number of funded projects, the types of artistic disciplines supported, and the geographical spread of these initiatives across the eligible counties. The grants are expected to range from $1,000 to $5,000 per project, ensuring that a greater number of smaller-scale, impactful projects can be realized. This strategic approach reflects the GCA's theory of change, which posits that by decentralizing arts funding and making it accessible to a wider range of organizations and counties, they can cultivate more vibrant, culturally rich communities throughout the state.

This funding opportunity supports institutions in creating collaborative training networks for early-career researchers focused on advancing studies in kidney, urologic, and hematologic diseases.

This funding opportunity provides substantial financial support to higher education institutions and nonprofit organizations to establish collaborative centers that advance research and resources for HIV/AIDS.

This grant provides funding to support small farmers and public entities in Maryland to aggregate local food products for sale to wholesale and institutional markets, enhancing the local food system.

This funding opportunity provides financial support to schools and school districts to conduct a pilot study aimed at reducing harmful contaminants in meals served to students and improving their nutritional quality.

The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization may be submitted to this FOA. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this FOA, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time. Accidental exposure of these products to alcohol can result in the relatively rapid release of large quantities of drug with severe side effects, including death. To mitigate this risk, the FDA recommends conducting an in vitro alcohol dose dumping assessment in 0%, 5%, 20%, and 40% alcoholic dissolution media for all prospective generic versions of MR oral drug products. To date, ADD assessments have not been harmonized globally. For instance, the U.S. FDA recommends testing up to 40% alcoholic media while the European Medicines Agency recommends testing up to 20% alcoholic media. This type of difference can present a challenge for formulators designing products for multiple markets, as historical data has shown release from MR oral products do not always follow a linear response (either increasing or decreasing) to increasing alcohol concentrations. In addition, interpretation of an ADD assessment may be limited by the inability of the test to predict in vivo behavior. The purpose of this research is to develop tools that 1) facilitate the development of MR generic drug products that have a low potential for ADD, 2) support regulatory decision making during the assessment of such products, and 3) provide evidence that enables FDA to develop more specific recommendations for efficiently demonstrating a low or comparative potential of alcohol dose dumping for MR oral drug products containing high risk drugs.

This funding opportunity supports researchers in discovering and validating new targets for developing safe and effective pain treatments with minimal side effects and low addiction risk.

Cox Communications, in partnership with the Arizona Community Foundation, offers grants through Cox Charities to support nonprofit organizations in Arizona. This program aligns with the foundation's mission to enhance communities by investing in key areas. Eligible organizations include Arizona 501(c)(3) entities, government agencies, and tribal entities, with religious organizations able to apply for non-sectarian programs. The program aims to foster positive community impact by supporting initiatives that address critical social needs within the state. The Cox Charities grant program targets beneficiaries across several key focus areas: Education, with a priority on K-12 and STEAM initiatives; Diversity, specifically programs serving 80% or more of a target population or promoting inclusion, diversity, and equity; Environment/Sustainability, focusing on water conservation, waste reduction, or carbon reduction; and Digital Equity, supporting digital literacy programs, computer distribution, or services for underserved communities. These priorities reflect the foundation's strategic focus on empowering individuals and communities through access to essential resources and opportunities. The expected outcomes of the Cox Charities grant program are centered on measurable results within these focus areas. For education, the goal is to improve educational attainment and skills, particularly in STEM fields. Diversity initiatives aim to foster more inclusive communities and reduce disparities. Environmental grants seek tangible improvements in sustainability practices, such as reduced water consumption or waste. Digital equity programs are expected to increase digital literacy and access, bridging the digital divide for underserved populations. The grant duration is not specified, but grants typically range from $2,500 to $10,000. The foundation's strategic priorities and theory of change are evident in its commitment to supporting programs that directly address identified community needs and create lasting impact. By prioritizing specific areas like K-12 and STEAM education, targeted diversity programs, environmental sustainability, and digital literacy, Cox Charities aims to drive systemic change. They emphasize fiscal accountability and responsibility among applicants, and organizations must demonstrate a non-discrimination policy. Furthermore, providing opportunities for Cox Communications Arizona employees to volunteer or serve on boards highlights a belief in community engagement and shared responsibility for achieving these outcomes.

The Toxics Use Reduction Institute (TURI) is offering a grant program to academic faculty focused on identifying, evaluating, and developing safer alternatives to per- and polyfluoroalkyl substances (PFAS). This initiative aligns with TURI's mission to reduce the use of toxic chemicals and promote safer practices. The program seeks to foster research that directly addresses the environmental and health concerns associated with PFAS by finding viable replacements in various manufacturing and product applications. The primary beneficiaries of this grant are academic faculty and their graduate students located at institutions within Massachusetts. The program aims to support these researchers in conducting innovative studies that contribute to a cleaner environment and safer products for the general public. The impact goals are to reduce reliance on PFAS, mitigate their toxic effects, and encourage the adoption of less harmful alternatives across industries. The grant prioritizes research that focuses on specific applications where PFAS are commonly used, such as water and stain-resistant coated fabrics, textiles, apparel, footwear, surfactant applications (including fume suppressants), refrigerants and coolants, fire suppressants, fluoropolymers, manufacturing processing aids, coated food packaging, and other non-stick coated materials and products. Proposals should directly address these areas to develop practical and implementable solutions. Expected outcomes include the identification of novel, safer alternatives to PFAS, comprehensive evaluations of existing alternatives, and the development of new processes or materials that eliminate the need for PFAS. Measurable results would involve the number of alternatives identified and evaluated, the success rate of developed alternatives in specific applications, and the potential for widespread adoption by industries. TURI's strategic priority is to drive toxics use reduction through research and education, and this grant program embodies a key part of their theory of change by funding scientific inquiry into tangible solutions for harmful chemicals.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at these applicant institutions. Eligible institutions must award baccalaureate science degrees, and have received less than 6 million dollars per year of NIH support (total costs) in 4 of the last 7 fiscal years.

This grant provides funding to nonprofit organizations and educational institutions in specific Pennsylvania counties to develop workforce skills and enhance economic development initiatives.

This program provides funding to support businesses and organizations involved in processing, storing, and distributing locally produced food in Michigan, helping to strengthen the state's food supply chain.

This Funding Opportunity Announcement (FOA) seeks innovative grant applications in nonmalignant hematology research that will steer the field in new directions. Applications to this FOA should propose proof of principle research that is tightly focused into one specific aim, which can be accomplished within a 1-3 year project period, and is directed at validating novel concepts and approaches that promise to open new pathways for discovery.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build research activities in nonmalignant hematology. This Funding Opportunity Announcement (FOA) is intended to promote innovative research projects in nonmalignant hematology that explore high impact and new directions of inquiry. While each Institute shares interests in nonmalignant hematology research, they also bring different perspectives, thereby expanding the scope of the SHINE II program beyond a single Institute's research mission. This "New Directions in Hematology Research (SHINE-II)" program invites investigator-initiated grant applications for basic or early translational, proof of principle research projects that are tightly focused and directed at validating novel concepts and approaches that promise to advance new pathways for discovery. This program may include clinical research involving human subjects that is directed at understanding disease pathogenesis and prognosis. Research applications submitted under this FOA should be more limited in scope (single aim with sub-aims, as appropriate) and duration (1-3 years) than typical R01 grant applications. The SHINE-II FOA seeks specifically to promote and support new directions of research in their early stages. Applications submitted to this FOA should include preliminary data that support the conceptual basis of the research proposed and the technical approaches to be used. Moreover, while research applications submitted under this FOA are expected to be more limited in scope and shorter in duration than typical R01 applications, achievement of the research objective(s) proposed should validate novel pathways of discovery and provide the basis for future high impact research endeavors. Principal areas of interest for this collaborative FOA include: (1) hematopoietic stem cell biology, (2) lineage fate determinants, (3) aging-related immune dysfunction and lymphocyte biology, (4) myeloid cell biology, and myelopoiesis, (5) platelet biology and dysfunction, (6) erythroid cell biology and erythropoiesis, (7) the molecular biology of heme and hemoglobin, (8) acquired and congenital disorders of red blood cell production and survival leading to chronic anemia or bone marrow failure, (9) and the uptake, utilization, storage, and transport of iron in health and disease. Inquiries to Scientific/Research staff prior to submission of an application to this FOA are strongly encouraged to discuss programmatic relevance and potential time tables for funding (see below, Section VII. Agency Contacts). The limited scope and shorter duration of the SHINE II R01 are not optimal for Early Stage Investigators (ESIs) and New Investigators (NIs), who should contact Scientific/Research staff prior to submission of an application to this FOA.

This funding opportunity supports educators in Lancaster County, Fort Lawn, and Great Falls, South Carolina, by providing financial resources for innovative and collaborative projects that enhance student learning.

The City of Boulder Health Equity Fund (HEF) Request for Proposals (RFP) is designed to support community-based health equity programs for Boulder residents experiencing health disparities. The fund aims to reduce systemic socio-economic and health barriers, aligning with the city's mission to achieve health equity—defined as the absence of systematic health disparities and the ability of all residents to reach their full health potential regardless of life circumstances. This initiative directly supports health and wellness programs that address these disparities. The target beneficiaries of the HEF include residents disproportionately impacted by diseases linked to sugar-sweetened beverage consumption or targeted by SSB marketing, those lacking access to healthy food, safe water, quality health care, wellness information, and health care services, and populations systemically disenfranchised due to race, ethnicity, income, age, ability, sexual orientation, or gender identification. The primary impact goal is to improve health equity and reduce health disparities within these vulnerable communities. The HEF prioritizes programs that benefit individuals most affected by or at increased risk from chronic diseases linked to sugary drink consumption, or who generally experience health disparities. Key focuses include health services for prevention of obesity, diabetes, heart disease, and oral diseases, increased access to healthy food and clean water, wellness programs, and physical fitness. The program also emphasizes leadership diversity reflective of client demographics, alignment with program priorities, evidence-based practices, and valuing lived experience and cultural knowledge. Expected outcomes and measurable results include long-term evaluation of outcomes, meaningful engagement of community members in program design and implementation, strong collaborations, cost-effectiveness, and demonstrated financial stability and diverse funding sources for applying agencies. The City of Boulder's strategic priority is to fund programs that directly address health inequities and contribute to a community where all residents can achieve their full health potential. The underlying theory of change is that by investing in targeted, community-based health and wellness programs, the city can systematically dismantle health barriers and create a more equitable health landscape for its residents.